Pathstone Holdings’s CollPlant Biotechnologies CLGN Stock Holding History

Pathstone Holdings’s Portfolio CLGN Stock Details CLGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.9K	Hold	5,700	–	–	﹤0.01%	2326
2026 Q1	$30.6K	Buy	5,700 +4,000	+235%	+$40.4K	﹤0.01%	2200
2025 Q4	$23.8K	Hold	1,700	–	–	﹤0.01%	2208
2025 Q3	$45.7K	Sell	1,700 -1,700	-50%	-$40.5K	﹤0.01%	2310
2025 Q2	$23.1K	Buy	3,400 +1,700	+100%	+$35.2K	﹤0.01%	2166
2025 Q1	$43.9K	Hold	1,700	–	–	﹤0.01%	2182
2024 Q4	$61.2K	Hold	1,700	–	–	﹤0.01%	2256
2024 Q3	$84.4K	Buy	+1,700	New	+$83.2K	﹤0.01%	2252

Other funds holding CLGN

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

LWMI

Legacy Wealth Management (Idaho) Boise, Idaho $243M AUM 8.27% 1-Year Est. Return

WPC

Waters Parkerson & Co New Orleans, Louisiana $2.03B AUM 17.65% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Pathstone Holdings's CLGN Position: Q2 2026 in Review

Pathstone Holdings held its CollPlant Biotechnologies (CLGN) position steady in Q2 2026 at 5,700 shares worth $19.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2326.

Pathstone Holdings first reported a position in CLGN in Q3 2024 and has held it in 8 quarters since. The position peaked at $84.4K in Q3 2024. 15 funds tracked by Wall St. Rank hold CLGN as of Q2 2026.

Pathstone Holdings held 5,700 shares of CollPlant Biotechnologies worth $19.9K as of Q2 2026.
Pathstone Holdings left its CollPlant Biotechnologies share count unchanged in Q2 2026.
CollPlant Biotechnologies made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #2326 holding.
Pathstone Holdings first reported a position in CollPlant Biotechnologies in Q3 2024 and has held it in 8 quarters since.
Pathstone Holdings's CollPlant Biotechnologies position peaked at $84.4K in Q3 2024.
15 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.